You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • OP0114 Secukinumab for The Treatment of Ankylosing Spondylitis: Comparative Effectiveness Results versus Adalimumab Using A Matching-Adjusted Indirect Comparison

Article metrics

Article menu
Download PDFPDF
Oral Presentations
Expanding therapeutic options in spondyloarthritis
OP0114 Secukinumab for The Treatment of Ankylosing Spondylitis: Comparative Effectiveness Results versus Adalimumab Using A Matching-Adjusted Indirect Comparison

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 2016904
Aug 2016601
Sep 20161303
Oct 20162003
Nov 201640015
Dec 20162402
Jan 20172906
Feb 201724012
Mar 20171301
Apr 201739013
May 201720013
Jun 2017900
Jul 20171407
Aug 201746013
Sep 201734013
Oct 201748015
Nov 201742011
Dec 20174003
Jan 20185008
Feb 20183401
Mar 20185205
Apr 20184802
May 201838010
Jun 20182604
Jul 201842014
Aug 20183008
Sep 20182202
Oct 20183603
Nov 20185409
Dec 20181401
Jan 20191800
Feb 20191803
Mar 20191202
Apr 2019801
May 20192401
Jun 2019600
Jul 20192403
Aug 20192403
Sep 20191401
Oct 20192000
Nov 20191202
Dec 20192400
Jan 20202600
Feb 20201202
Mar 2020400
May 20202000
Jun 20201600
Jul 20201600
Aug 20202002
Sep 20202600
Oct 20201601
Nov 2020500
Dec 2020800
Jan 2021801
Feb 2021400
Mar 20212600
Apr 20211400
May 2021200
Jul 2021200
Oct 20212201
Nov 20211201
Dec 20211000
Jan 2022800
Feb 20221102
Mar 2022200
Apr 20222500
May 2022900
Jun 2022800
Jul 20222200
Aug 20221501
Sep 20221200
Oct 20221300
Nov 20221300
Dec 20221601
Jan 2023702
Feb 20232300
Mar 20231200
Apr 2023800
May 20231300
Jun 20231100
Jul 2023700
Aug 2023900
Sep 20231800
Oct 20231300
Nov 2023500
Dec 20232901
Jan 2024200
Feb 2024900
Mar 20241000
Total17190233